SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001694665-18-000010
Filing Date
2018-11-02
Accepted
2018-11-02 09:04:19
Documents
68
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eveloq310-q2018.htm 10-Q 1181564
2 EXHIBIT 31.1 eveloq32018exhibit311.htm EX-31.1 19603
3 EXHIBIT 31.2 eveloq32018exhibit312.htm EX-31.2 19562
4 EXHIBIT 32.1 eveloq32018exhibit321.htm EX-32.1 10882
5 EXHIBIT 32.2 eveloq32018exhibit322.htm EX-32.2 10822
  Complete submission text file 0001694665-18-000010.txt   5125661

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT evlo-20180930.xml EX-101.INS 793660
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT evlo-20180930.xsd EX-101.SCH 40219
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT evlo-20180930_cal.xml EX-101.CAL 66754
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT evlo-20180930_def.xml EX-101.DEF 205900
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT evlo-20180930_lab.xml EX-101.LAB 579429
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT evlo-20180930_pre.xml EX-101.PRE 353382
Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Filer) CIK: 0001694665 (see all company filings)

IRS No.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38473 | Film No.: 181155610
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1